Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-03-16

Clinical Trial Update: Validation of Aspiration Markers [Phase 1]

View source ↗

Summary

Phase 1 trial to validate aspiration biomarkers for aspiration pneumonia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pneumonia, Aspiration | Phase 1 | Status: WITHDRAWN